To,
The Members,
QMS Medical Allied Services Limited
Your Directors take pleasure in presenting their Eighth Annual Report on the Business and Operations of the Company and the Accounts for the Financial Year ended 31st March, 2025 (period under review).
1. FINANCIAL SUMMARY/PERFORMANCE OF THE COMPANY:
The summary of standalone financial highlights for the financial year ended March 31, 2025 and the previous financial year ended March 31, 2024 is given below:
Amount in lakhs.
Particulars | 2024-2025 | 2023-2024 |
Total revenue for the year | 14,532.32 | 12,258.36 |
Profit before depreciation, exceptional Items & Taxes | 1,782 | 1567.59 |
Depreciation for the year | 339.83 | 344 |
Profit before exceptional items | 1,442.17 | 1223.59 |
Exceptional items | - | - |
Profit/(loss) before tax | 1,442.17 | 1223.59 |
Tax for the year (including deferred tax - net) | 400.10 | 323.34 |
Net profit / (loss) | 1,042.06 | 900.24 |
FINANCIAL PERFORMANCE:
The Total Income of the Company stood at Rs. 14,486.74 (Rs. In Lakhs)for the year ended March 31, 2025 as against Rs. 12,258.36 (Rs. In Lakhs)/- in the previous year. The Company has a Net Profit of Rs. 1,042.06(Rs. In Lakhs)for the year ended March 31, 2025 as compared to the Net Profit of Rs. 900.24 (Rs. In Lakhs)- in the previous year.
2. CONSOLIDATED FINANCIAL STATEMENTS:
The summary of Consolidated financial highlights for the financial year ended March 31, 2025 and the previous financial year ended March 31, 2024 is given below.
The Company did not have any Subsidiary, Associate, or Joint Venture Company as on March 31, 2024. The information presented herein is provided solely for comparative purposes
Amount in lakhs.
Particulars | 2024-2025 | 2023-2024 |
Total revenue for the year | 15,772.99 | 12,258.36 |
Profit before depreciation, exceptional Items & Taxes | 2248.75 | 1567.59 |
Depreciation for the year | 382.54 | 344 |
Profit before exceptional items | 1,866.21 | 1223.59 |
Exceptional items | - | - |
Profit/(loss) before tax | 1,866.21 | 1223.59 |
Tax for the year (including deferred tax - net) | 496.37 | 323.34 |
Net profit / (loss) | 1,369.84 | 900.24 |
3. DIVIDEND:
The Board at its meeting held on May 29, 2025 has recommended Dividend of Rs. 0.50 (i.e. 5%) per equity share of 10/- each for the financial year 2024-25. The dividend pay-out is subject to the approval of the shareholders at ensuing Annual General Meeting.
The Record date fixed for determining entitlement of Members to final dividend for the financial year ended 31st March, 2025 is Monday, September 22, 2025. The Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, September 23, 2025 to Monday, September 29, 2025 (both days inclusive) in terms of the provisions of Section 91 of the Companies Act, 2013.
Dividend of Rs. 0.50 (i.e. 5%) per equity share of 10/- each was declared and paid for the financial year 2023-24.
4. SHARE CAPITAL
Authorised Capital
The Authorised Share Capital of the Company as on 31st March, 2025 is Rs. 23,00,00,000/- (Rupees Twenty Three Crore only) divided into 2,30,00,000 (Two Crore Thirty Lakhs) Equity shares of Rs. 10/- (Rupees Ten only) each.
Issued, Subscribed and Paid up Capital:
The Issued, Subscribed and Paid up Capital of the Company as at 31st March, 2025 is Rs. 17,85,00,000/- (Rupees Seventeen Crores Eighty Five Lakhs Only) divided into 1,78,50,000 (One Crore Seventy Eight Lakhs Fifty Thousand) Equity Shares having face value of Rs. 10/- (Rupees Ten Only) each.
Any issue of securities made during the year are as follows:
Issue of shares or other convertible securities - Nil
Issue of equity shares with differential rights - Nil
Issue of Sweat Equity Shares - Nil
Details of Employee Stock Options - Nil
Shares held in trust for the benefit of employees where the voting rights are not exercised directly by the employees - Nil
Issue of debentures, bonds or any non-convertible securities- Nil
Issue of warrants - Nil
Issue of Bonus Shares - Nil
The Company in the Financial Year 2023-24 vide its Board meeting dated 2nd February, 2024 has passed the resolution for Issuance of 7,50,000 Share warrants on Preferential basis and 22,69,000 Equity shares on Preferential basis. Further the Company vide Special Resolution passed in its Extra Ordinary General Meeting held on 26th February, 2024, approved the Issuance of 7,50,000 Share warrants on Preferential basis and 22,69,000 Equity shares on Preferential basis. Later, the Application was withdrawn voluntarily by the Company prior to In principle approval of NSE. The application was withdrawn voluntarily as the objective of preferential issue was to utilize such funds for acquisitions and the funds were arranged from other sources.
5. DETAILS OF LOCK - IN OF SHARES:
In line with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, below are the details of the lock-in Shares of the Company held by Promoters and Public Shareholders:
Name of the Shareholder | Category | Quantity | Lock-in till one year (22-102023) | Lock-in for three years (2210-2025) |
Mr. Mahesh Pahalraj Makhija | Promoter | 1,28,48,840 | 92,78,840 | 35,70,000 |
Mrs. Guddi Mahesh Makhija | Promoter group | 1,50,500 | 1,50,500 | 0 |
Ms. Diti Mahesh Makhija | Promoter group | 1,50,500 | 1,50,500 | 0 |
Mr. Arul Dhass David | Public Shareholder | 40 | 40 | 0 |
Mr. Abhishek Tiwari | Public Shareholder | 40 | 40 | 0 |
Mr. Koushik Thakurta | Public Shareholder | 40 | 40 | 0 |
Mr. Charles James | Public Shareholder | 40 | 40 | 0 |
6. TRANSFER TO RESERVE:
The Company has not transferred any amount to the General Reserves during the year.
7. UNPAID DIVIDEND & IEPF:
The Company was not required to transfer any amount to the Investor Education & Protection Fund (IEPF).
8. STATE OF AFFAIRS OF THE COMPANY:
Information on the operations and financial performance, among others for the period under review, is given in the Management Discussion and Analysis Report which is annexed to this Report as an Annexure V and is in accordance with the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
9. ALTERATION IN MEMORANDUM OF ASSOCIATION:
There has been no change in any clause of the Memorandum of Association by virtue of Section 13 of the Companies Act, 2013, during the Financial Year under review.
10. DIRECTORS AND KEY MANAGERIAL PERSONNEL:
(a) Composition & Constitution of Board of Directors:
The Board of Directors as on date comprises of following Directors:
Sr. No. | Name | DIN/ PAN | Designation |
1. | Mr. Mahesh Pahalraj Makhija | 02700606 | Chairman, Managing Director, Promoter |
2. | *Sarita Vijay Mahajan | 10841279 | Non-Executive Independent Woman Director |
3. | Mr. Prajwal Jayasheela Poojari | 07480513 | Non-Executive Independent Director |
4. | Mr. Niken Ravin Shah | 07604022 | Non-Executive Independent Director |
5. | **Mr. Deena Nath Pathak | 02104727 | Non-Executive Director |
6. | ***Mrs. Guddi Makhija (Resigned on August 23, 2024) | 08837871 | Non-Executive NonIndependent Director |
*Ms. Sarita Vijay Mahajan was appointed as a Woman Independent Director on January 30, 2025.
** Mr. Deena Nath Pathak (DIN: 02104727) as an Additional Non-Executive Director on August 23, 2024 and regularized in AGM dated September 27, 2024.
***Mrs. Guddi Makhija (DIN: 08837871), Non-Executive Non-Independent Director, has resigned from the Board w.e.f August 23, 2024
(b) Composition & Constitution of Key Managerial Personnel:
The Key Managerial Personnels as on date comprises of following:
Sr. | Name | DIN/ PAN | Designation |
1. | Mrs. Toral Jailesh Bhadra | BNJPG6249Q | Company Secretary and Compliance Officer |
2. | Mrs. Sejal Vivek Mhatre | ASLPM7957P | Chief Financial Officer |
(c) Retirement by Rotation of the Directors
Independent directors hold office for a fixed term not exceeding five years from the date of their appointment and are not liable to retire by rotation.
The Act mandates that at least two-thirds of the total number of directors (excluding independent directors) shall be liable to retire by rotation.
In terms of Section 152 of the Companies Act, 2013, Mr. Mahesh Makhija Makhija (DIN: 02700606), retire by rotation and being eligible offer themselves for re-appointment at the 8th Annual General Meeting of the company scheduled to be held on Monday, September 29, 2025.
11. RECONCILIATION OF SHARE CAPITAL AUDIT :
As stipulated by SEBI, a qualified Practicing Company Secretary carries out the quarterly reconciliation of the total Share capital held with the National Security Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) and the total issued and listed share capital and the report thereon is submitted to the National Stock Exchange of India Limited. The report, inter alia, confirms that the number of shares issued, listed on the Stock exchange and that held in demat mode are in agreement with each other.
12. INDEPENDENT DIRECTORS :
(a) Declaration by Independent Directors
Independent Directors have provided their confirmation, that they meet the criteria of independence as provided in sub- section (6) of Section 149 of the Companies Act, 2013. An Independent Director shall hold office for a term up to five consecutive years on the Board of a Company, but shall be eligible for reappointment for the next five years on the passing of a special resolution by the Company.
(b) Changes in Independent Director
The Company has appointed Mrs. Sarita Vijay Mahajan (DIN: 10841279) as an Independent Director during the year 2024-25. .
(c) Familiarisation Programme for Independent Directors:
The Company through its Executive Directors / Senior Managerial Personnel conduct programs / presentations periodically to familiarize the Independent Directors with the strategy, operations and functions of the Company. Such programs / presentations will provide an opportunity to the Independent Directors to interact with the senior leadership team of the Company and help them to understand the Companys strategy, business model, operations, service and product offerings, markets, organization structure, finance, human resources, technology, quality, facilities and risk management and such other areas as may arise from time to time. The programs / presentations shall also familiarize the Independent Directors with their roles, rights and responsibilities.
The Company circulate news and articles related to the industry on a regular basis and may provide specific regulatory updates from time to time and The Company conduct an introductory familiarization program / presentation, when a new Independent Director comes on the Board of the Company.
(d) Meetings
During the year under review, the Independent Directors met for 01(one) time. The details of Board Meeting held and participation of Directors thereat is enumerated as below:
Sr. No. | Date of meeting | Total No. of Independent Directors on the Date of Meeting | No. of Independent Directors attended | % of Attendance |
1 | 18-03-2025 | 02 | 02 | 100.00 |
13. MEETINGS:
During the year under review, the Board of your Company met Twelve (12) times in the year 2024-2025. The details of Board Meeting held and participation of Directors thereat is enumerated as below:
Sr. No. | Date of meeting | Total No. of Directors on the Date of Meeting | No. of Directors attended | % of Attendance |
1 | 23-05-2024 | 04 | 04 | 100.00 |
2 | 06-06-2024 | 04 | 04 | 100.00 |
3 | 13-08-2024 | 04 | 04 | 100.00 |
4 | 23-08-2024 | 04 | 04 | 100.00 |
5 | 29-08-2024 | 04 | 04 | 100.00 |
6 | 22-10-2024 | 04 | 04 | 100.00 |
7 | 14-11-2024 | 04 | 04 | 100.00 |
8 | 19-11-2024 | 05 | 05 | 100.00 |
9 | 02-12-2024 | 05 | 05 | 100.00 |
10 | 10-12-2024 | 05 | 05 | 100.00 |
11 | 23-12-2024 | 05 | 05 | 100.00 |
12 | 14-02-2025 | 05 | 05 | 100.00 |
The details of Board Meetings held from April 01, 2024 to March 31, 2025 and attendance of each Director thereat is as follows:
Sr. No. | Name of the Board Member | No. of Meetings entitled to attend | No. of Meetings attended | % of Attendance |
1. | Mahesh Pahalraj Makhija | 12 | 12 | 100 |
2. | Guddi Makhija | 04 | 04 | 100 |
3. | Niken Ravin Shah | 12 | 12 | 100 |
4. | Prajwal Jayasheela Poojari | 12 | 12 | 100 |
5 | Sarita Vijay Mahajan | 05 | 05 | 100 |
6 | Deena Nath Pathak | 08 | 08 | 100 |
14. COMMITTEES OF BOARD:
As on 31st March, 2025, our Board has constituted the following committees.
The Composition of Audit Committee as on 31st March, 2025 is as follows:
i. AUDIT COMMITTEE:
Mr. Prajwal Jayasheela Poojari - Chairman, Non-Executive Independent Director
Mr. Deena Nath Pathak - Member, Non - Executive Director
Mr. Niken Ravin Shah - Member, Non-Executive Independent Director
The Committee was reconstituted due to resignation of Ms. Guddi Makhija and appointment of Mr. Deena Nath Pathak as a Non Executive Director with effect from 23rd August, 2024.
The Audit Committee of Directors was constituted pursuant to the provisions of Section 177 of the Companies Act, 2013. The composition of the Audit Committee is in conformity with the provisions of the said section. The Audit Committee met Seven (7) times during the financial year ended 31st March, 2025 .
Sr. No. | Date of meeting | Total No. of Directors on the Date of Meeting | No. of Directors attended | % of Attendance |
1 | 23-05-2024 | 03 | 03 | 100% |
2 | 13-08-2024 | 03 | 03 | 100% |
3 | 23-08-2024 | 03 | 03 | 100% |
4 | 14-11-2024 | 03 | 03 | 100% |
5 | 02-12-2024 | 03 | 03 | 100% |
6 | 10-12-2024 | 03 | 03 | 100% |
7 | 14-02-2025 | 03 | 03 | 100% |
The details of Audit Committee Meetings held from April 01, 2024 to March 31, 2025 and attendance of each Director thereat is as follows:
Sr. No. | Name of the Committee Member | No. of Committee Meetings entitled to attend | No. of Meetings attended | % of Attendance |
1. | Niken Ravin Shah | 07 | 07 | 100% |
2. | Prajwal Jayasheela Poojari | 07 | 07 | 100% |
3. | Guddi Makhija | 03 | 03 | 100% |
4. | Deena Nath Pathak | 04 | 04 | 100% |
The Committee is governed by a terms of reference, which is in line with the regulatory requirements mane the Companies Act, 2013. Some of the important functions performed by the Committee are:
1. Oversight of the Companys financial reporting process and the disclosure of its financial inform ensure that the financial statements are correct, sufficient and credible;
2. Recommendation for appointment, remuneration and terms of appointment of auditors of our Com:
3. Approval of payment to statutory auditors for any other services rendered by the statutory auditors;
4. Reviewing, with the management, the annual financial statements and auditors report thereor submission to our Board for approval, with particular reference to:
Matters required to be included in the Directors Responsibility Statement, to be includee Boards report in terms of clause (c) of sub-section 3 of section 134 of the Companies Act;
Changes, if any, in accounting policies and practices and reasons for the same;
Major accounting entries involving estimates based on the exercise of judgment by managemer
Significant adjustments made in the financial statements arising out of audit findings;
Compliance with listing and other legal requirements relating to financial statements;
Disclosure of any related party transactions; and
modified opinion(s) in the draft audit report.
5. Reviewing, with the management, the quarterly financial statements before submission to our Board for approval;
6. Reviewing, with the management, the statement of uses / application of funds raised through an issue (public issue, rights issue, preferential issue, etc.), the statement of funds utilized for purposes other than those stated in the offer document / prospectus / notice and the report submitted by the monitoring agency monitoring the utilization of proceeds of a public or rights issue, and making appropriate recommendations to our Board to take up steps in this matter;
7. Reviewing and monitoring the auditors independence and performance, and effectiveness of audit process;
8. Approval of any subsequent modification of transactions of our Company with related parties;
9. Scrutiny of inter-corporate loans and investments;
10. Valuation of undertakings or assets of our Company, wherever it is necessary;
11. Evaluation of internal financial controls and risk management systems;
12. Reviewing, with the management, performance of statutory and internal auditors, adequacy of the internal control systems
13. Reviewing the adequacy of internal audit function, if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage and frequency of internal audit;
14. Discussion with internal auditors of any significant findings and follow up thereon;
15. Reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to our Board;
16. Discussion with statutory auditors before the audit commences, about the nsature and scope of audit as well as post- audit discussion to ascertain any area of concern;
17. Looking into the reasons for substantial defaults in the payment to depositors, debenture holders, shareholders (in case of non-payment of declared dividends) and creditors;
18. Reviewing the functioning of the whistle blower mechanism;
19. Approval of appointment of CFO (i.e., the whole-time finance Director or any other person heading the finance function or discharging that function) after assessing the qualifications, experience and background, etc. of the candidate;
20. Carrying out any other function as is mentioned in the terms of reference of the Audit Committee.
21. reviewing the utilization of loans and/ or advances from/investment by the holding company in the subsidiary exceeding rupees 100 crore or 10% of the asset size of the subsidiary, whichever is lower including existing loans / advances / investments existing as on the date of coming into force of this provision.]
22. consider and comment on rationale, cost-benefits and impact of schemes involving merger, demerger, amalgamation etc., on the listed entity and its shareholders.
23. Carrying out any other function as may be mentioned in the terms of reference of the Audit Committee.
All the Members on the Audit Committee have the requisite qualification for appointment on the Committee and possess sound knowledge of finance, accounting practices and internal controls.
The Company Secretary acts as the Secretary to the Committee.
ii. NOMINATION AND REMUNERATION COMMITTEE:
As on 31st March, 2025 the Composition of Nomination and Remuneration Committee is as follows:
Mr. Niken Ravin Shah - Chairman, Non-Executive Independent Director
Mr. Prajwal Jayasheela Poojari - Member, Non-Executive Independent Director
Mr. Deena Nath Pathak - Member, Non - Executive Director
The Committee was reconstituted due to resignation of Ms. Guddi Makhija and appointment of Mr. Deena Nath Pathak as a Non Executive Director with effect from 23rd August, 2024.
The Board has in accordance with the provisions of sub-section (3) of Section 178 of the Companies Act, 2013, formulated the policy setting out the criteria for determining qualifications, positive attributes, independence of a Director and policy relating to remuneration for Directors, Key Managerial Personnel and other employees.
During the year, the committee met 3(Three) times with full attendance of all the members. The composition of the Nomination and Remuneration Committee as of March 31, 2025 and details of the Members participation at the Meetings of the Committee are as under:
Sr.No. | Date of meeting | Total No. of Directors on the Date of Meeting | No. of Directors attended | %of Attendance |
1 | 23-08-2024 | 03 | 03 | 100% |
2 | 29-08-2024 | 03 | 03 | 100% |
3 | 19-11-2024 | 03 | 03 | 100% |
The details of Nomination and Remuneration Committee Meetings held from April 01, 2024 to March 31, 2025 and attendance of each Director thereat is as follows:
Sr. No. | Name of the Committee Member | No. of Committee Meetings entitled to attend | No. of Meetings attended | % of Attendance |
1. | Mr. Niken Ravin Shah | 03 | 03 | 100% |
2. | Mr. Prajwal Jayasheela Poojari | 03 | 03 | 100% |
3. | Ms. Guddi Makhija | 01 | 01 | 100% |
4. | Mr. Deena Nath Pathak | 02 | 02 | 100% |
The terms of reference of the Committee inter alia, include the following:
1. Formulation of the criteria for determining qualifications, positive attributes and independence of a Director and recommend to our Board a policy relating to the remuneration of the Directors, key managerial personnel and other employees;
2. For every appointment of an independent director, the Nomination and Remuneration Committee shall evaluate the balance of skills, knowledge and experience on the Board and on the basis of such evaluation, prepare a description of the role and capabilities required of an independent director. The person recommended to the Board for appointment as an independent director shall have the capabilities identified in such description. For the purpose of identifying suitable candidates, the Committee may:
a) use the services of an external agencies, if required;
b) consider candidates from a wide range of backgrounds, having due regard to diversity; and
c) consider the time commitments of the candidates
3. Formulation of criteria for evaluation of independent Directors and our Board;
4. Devising a policy on Board diversity;
5. Identifying persons who are qualified to become Directors and who may be appointed in senior management in accordance with the criteria laid down, and recommend to our Board their appointment and removal;
6. Whether to extend or continue the term of appointment of the independent director, on the basis of the report of performance evaluation of independent directors.
7. Recommend to the board, all remuneration, in whatever form, payable to senior management.
iii. STAKEHOLDERS RELATIONSHIP COMMITTEE:
As on 31st March, 2025 the Composition of Stakeholders Relationship Committee is as follows:
Mr. Prajwal Jayasheela Poojari - Chairman, Non-Executive Independent Director
Mr. Deena Nath Pathak - Member, Non - Executive Director
Mr. Niken Ravin Shah - Member, Non-Executive Independent Director
As on date the Committee was reconstituted on 23rd August, 2024, the Composition of Committee is consisting of the following members:
Mr. Prajwal Jayasheela Poojari - Chairman, Non-Executive Independent Director
Mr. Deena Nath Pathak - Member, Non - Executive Director
Mr. Niken Ravin Shah - Member, Non-Executive Independent Director
The Committee was reconstituted due to resignation of Ms. Guddi Makhija and appointment of Mr. Deena Nath Pathak as a Non Executive Director with effect from 23rd August, 2024.
The Company has Stakeholders Relationship Committee, as per Section 178 (5) of Companies Act, 2013.
During the year, the committee met once (1) time with full attendance of all the members. The composition of the Stakeholders Relationship Committee as at March 31, 2025 and details of the Members participation at the Meetings of the Committee are as under:
Sr. No. | Date of meeting | Total No. of Directors on the Date of Meeting | No. of Directors attended | % of Attendance |
1 | 18-03-2025 | 3 | 3 | 100% |
The details of Stakeholders Relationship Committee Meetings held from April 01, 2024 to March 31, 2025 and attendance of each Director thereat is as follows:
Sr. No. | Name of the Committee Member | No. of Committee Meetings entitled to attend | No. of Meetings attended | % of Attendance |
1. | Mr. Niken Ravin Shah | 1 | 1 | 100% |
2. | Mr. Prajwal Jayasheela Poojari | 1 | 1 | 100% |
3. | Mr. Deena Nath Pathak | 1 | 1 | 100% |
The terms of reference of the Committee are:
1. Resolving the grievances of the security holders of the listed entity including complaints related to transfer/transmission of shares, non-receipt of annual report, non-receipt of declared dividends, issue of new/duplicate certificates, general meetings etc.
2. Review of measures taken for effective exercise of voting rights by shareholders.
3. Review of adherence to the service standards adopted by the listed entity in respect of various services being rendered by the Registrar & Share Transfer Agent.
4. Review of the various measures and initiatives taken by the listed entity for reducing the quantum of unclaimed dividends and ensuring timely receipt of dividend warrants/annual reports/statutory notices by the shareholders of the company.
During the year, there were no complaints received from shareholder on SCORES. There are no balance complaints. The Company had no share transfers pending as on March 31, 2025 .
15. BOARD EVALUATION:
Your Board has devised an Evaluation Policy for evaluating the performance of the Board, its Committees, Executive Directors, Independent Directors. Based on the same, the performance was evaluated for the financial year ended March 31, 2025 . As part of the evaluation process, the performance of Non- Independent Directors, the Chairman and the Board was conducted by the Independent Directors. The performance evaluation of the respective Committees and that of Independent and Non- Independent Directors was done by the Board excluding the Director being evaluated.
The policy inter alia provides the criteria for performance evaluation such as Board effectiveness, quality of discussion, contribution at the meetings, business acumen, strategic thinking, time commitment and relationship with the stakeholders, corporate governance practices, contribution of the committees to the Board in discharging its functions etc.
The Board carried out formal annual evaluation of its own performance and that of its Committees viz., the Audit Committee, Stakeholders Relationship Committee, Nomination and Remuneration Committee (NRC). The Board also carried out the performance evaluation of all the individual Directors including the Chairman of the Company. Additionally, NRC also carried out the evaluation of the performance of all the individual Directors and Chairman of the Company. The performance evaluation was carried out by way of obtaining feedback from the Directors through a structured questionnaire prepared in accordance with the policy adopted by the Board and after taking into consideration the Guidance Note on Board Evaluation issued by Securities and Exchange Board of India.
16. ANNUAL RETURN:
In terms of Section 92(3) of the Companies Act, 2013 and Rule 12 of the Companies (Management and Administration) Rules, 2014, the Annual Return of the Company shall be available on the website of the Company https://qmsmas.com/
17. VARIOUS POLICIES OF THE COMPANY:
The Company has formulated and implemented various policies pursuant to the Companies Act, 2013 and SEBI (LODR) Regulations, 2015 which is available on the Companys website https://qmsmas.com/Policies.html.
The policies are reviewed periodically by the Board and updated based on need and requirements:
POSH Policy | This policy has been framed in accordance with the provisions of "The Sexual Harassment of Women at |
Workplace (Prevention, Prohibition and Redressal) Act, 2013" and rules framed thereunder (hereinafter "the Act") and provides protection against sexual harassment of women at workplace and the prevention and redressal of complaints of sexual harassment and matters related to it. | |
Nomination and Remuneration Policy | This Policy has been framed for the Appointment and Remuneration of Directors, Key Managerial Personnel and Senior Management Personnel and provides a framework based on which human resources management aligns their recruitment plans for strategic growth of the Company. |
Preservation of Documents and Archival Policy | This policy has a strategic objective of ensuring that significant documents as specified in this policy are safeguarded and preserved to ensure longevity of such documents. |
Policy Determination Materiality Disclosures Event Information | This policy applies for determining and disclosing material events taking place in the Company. |
Code of Conduct for Non-Executive Directors | The code of conduct for Non-Executive Directors to ensure the compliance of applicable laws, avoid conflict of interest and determine their duties in the company. |
Terms and Condition for Appointment of Independent Director | The policy provides framework that regulates the appointment, re-appointment of Independent directors and defines their roles, responsibilities and powers. |
Dividend Policy | Dividend Distribution Policy is not mandatory for our Company. |
Vigil Mechanism | This policy establishes a Vigil Mechanism (Whistle Blower Mechanism) that provides a channel to the employees and Directors of the Company to report to the Management instances of unethical behavior, actual or suspected fraud or violation of the Companys code of conduct. The vigil mechanism is required to provide adequate safeguards against victimization of persons who use such mechanisms. |
Code of Practices and Procedures - UPSI | The code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information without advantage to any particular person(s). |
CSR POLICY |
The objective of the CSR Policy ("Policy") is to lay down the guiding principles in undertaking various Programs and projects by or on behalf of the company relating to Corporate Social Responsibility ("CSR") |
18. AUDITORS:
i. Statutory Auditor:
The company in the Annual General Meeting held on September 27, 2024, appointed M/s. H.H. Dedhia & Associates, Chartered Accountants, (ICAI Firm Registration No. 148213W) as the Statutory Auditor of the Company for the period for 5 years who shall hold office from the 7th Annual General Meeting held on September 27, 2024 till the conclusion of 12th Annual General Meeting to be held in the year 2029 in respect of the financial years beginning from April 01, 2024 and ending with March 31, 2029.
The notes on financial statements referred to in the Auditors Report are self explanatory and do not call for any further comments and explanations. The Auditors Report does not contain any qualification, reservation or adverse remark. No instances of fraud have been reported by the Statutory Auditors of the Company under Section 143(12) of the Companies Act, 2013.
The Statutory Audit Report for the F.Y. 2024-25 does not contain any qualification, reservation or adverse remark. The Auditors have issued an unmodified opinion on the Financial Statements for the Financial Year ended 31st March, 2025. The Auditors Report for the Financial Year ended 31st March, 2025 on the financial statements of the Company is a part of this Annual Report.
ii. Secretarial Auditor:
In terms of Section 204 of the Act and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 M/s. Maharshi Ganatra & Associates (Firm Registration No. S2015MH305300), a firm of Company Secretaries in Practice, has been appointed as Secretarial Auditors of the Company.
The Report of the Secretarial Auditors is enclosed as Annexure I which forms part of this Report. There has been no qualification, reservation, adverse remark or disclaimer given by the Secretarial Auditors in their Report.
In accordance with the SEBI Listing Regulations, the Board of the Company have appointed. M/s. Maharshi Ganatra & Associates, a Peer reviewed firm, as the Secretarial Auditors of the Company for conducting Secretarial Audit and issue the Secretarial Audit Report for a term of consecutive five (5) years from Financial Year April 1, 2025 to March 31, 2030, subject to the approval of the Members of the Company at the ensuing Annual General Meeting
iii. Cost Auditor:
Appointment of Cost Auditor is not applicable to the Company.
iv. Internal Auditor:
Pursuant to the provisions of Section 138 of the Companies Act, 2013 and Companies (Accounts) Rules, 2014, the company has re-appointed M/s Khushbu Parekh & Co., Chartered Accountants (having Firm Registration No.: 145191W), as an Internal Auditor for the Financial Year 2024-2025 in the Board Meeting held on May 23, 2024.
19. MAINTENANCE OF COST RECORDS:
The maintenance of cost accounts and records as prescribed under Section 148(1) of the Companies Act, 2013 is not applicable to the Company.
20. VIGIL MECHANISM:
In pursuance of the provisions of section 177(9) & (10) of the Companies Act, 2013, a Vigil Mechanism for Directors and Employees to report genuine concerns has been established. Affirmation is also given that no personnel has been denied access to the audit committee.
The Vigil Mechanism policy is displayed on the website of the company, viz https://qmsmas.com/prospectus/Vigil mechanism.pdf
21. INTERNAL FINANCIAL CONTROLS:
The Company has put in place an adequate system of internal financial control commensurate with its size and nature of its business and continuously focuses on strengthening its internal control processes. These systems provide a reasonable assurance in respect of providing financial and operational information, complying with applicable statutes, safeguarding of assets of the Company and ensuring compliance with corporate policies. The internal financial control of the company is adequate to ensure the accuracy and completeness of the accounting records, timely preparation of reliable financial information, prevention and detection of frauds and errors, safeguarding of the assets, and that the business is conducted in an orderly and efficient manner.
Audit Committee periodically reviews the adequacy of Internal Financial controls. During the year, such controls were tested and no reportable material weaknesses were observed. The system also ensures that all transactions are appropriately authorized, recorded and reported.
22. RISK ASSESSMENT AND MANAGEMENT:
The Company has been on a continuous basis reviewing and streamlining its various operational and business risks involved in its business as part of its risk management policy. The Company also takes all efforts to train its employees from time to time to handle and minimize these risks.
23. DETAILS OF SUBSIDIARY/JOINT VENTURES/ASSOCIATE COMPANIES:
During the year under review, Saarathi Healthcare Private Limited became a subsidiary of the Company. The Company does not have any joint ventures or associate companies..
The Company had entered into Share Purchase Agreement on February 15, 2024 read with the Amendment Letter dated July 4, 2024 to acquire the shares of Saarathi Healthcare Private Limited for a consideration of Rs. 45,00,00,540/- (Rupees Forty-Five Crore and Five Hundred and Forty Only) in Tranches.
Further on July 5, 2024, the Company has acquired 51% stake of Saarathi Healthcare Private Limited and will now be considered as the Subsidiary of the Company.
24. COMPLIANCE WITH SECRETARIAL STANDARDS:
The Company is compliant with the applicable Secretarial Standards (SS) viz. SS-1 & SS-2 on Meetings of the Board of Directors and General Meetings, respectively.
25. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO:
i. Conservation of Energy:
a) The steps taken or impact on conservation of energy - The Operations of the Company are not energy intensive. However, adequate measures have been initiated for conservation of energy.
b) The steps taken by the Company for utilizing alternate source of energy - Company shall consider on adoption of alternate source of energy as and when necessities.
c) The Capital Investment on energy conversation equipment - No Capital Investment yet.
ii. Technology absorption:
a) The efforts made towards technology absorption - Minimum technology required for Business is absorbed.
b) The benefits derived like product improvement, cost reduction, product development or import substitution - Not Applicable.
c) In case of imported technology (imported during the last three years reckoned from the beginning of the financial year) - Not Applicable.
the details of technology imported;
the year of import;
whether the technology been fully absorbed;
if not fully absorbed, areas where absorption has not taken place, and the reasons thereof
iii. The expenditure incurred on Research and Development - Not Applicable.
iv. Foreign Exchange earnings and outgo:
Foreign Exchange used - Rs. 14,92,42,934/- Foreign Exchange earning - NIL
26. PARTICULARS OF LOANS, INVESTMENTS AND GUARANTEES:
Details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Companies Act, 2013 are given in the notes to the Financial Statements.
27. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:
All contracts / arrangements / transactions entered by the Company during the financial year with related parties were in the ordinary course of business and on an arms length basis. During the year, the Company had not entered into any contract / arrangement / transaction with related parties which could be considered material in accordance with the policy of the Company on materiality of related party transactions. Accordingly, the disclosure of Related Party Transactions as required under Section 134(3) of the Companies Act in Form AOC-2 is not applicable. Attention of the members is drawn to the disclosures of transactions with the related parties is set out in Notes to Accounts forming part of the financial statement.
28. DEPOSITS:
The Company has not invited /accepted any deposits from the public falling within the ambit of Section 73 of the Companies Act, 2013 and the Companies (Acceptance of Deposits) Rules, 2014.
29. SIGNIFICANT AND MATERIAL ORDERS:
There are no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and Companys operations in future.
30. DETAILS OF MATERIAL CHANGES AND COMMITMENTS AFFECTING FINANCIAL POSITION BETWEEN THE END OF THE FINANCIAL YEAR AND THE DATE OF REPORT:
There have been no material changes and commitments, affecting the financial position of the Company occurred between the end of the Financial year i.e. 31st March, 2025, to which the Financial Statements relate and the date of the report, if any, disclosed in separate respective head.
The Company in the Meeting held on August 25, 2025 had approved the issuance of Rights Shares for Raising of funds through issuance and allotment of equity shares for an aggregate amount not exceeding Rs. 12,50,00,000 (Rupees Twelve Crores Fifty Lakhs Only) on right basis, on such terms and conditions as may be decided by the Board of Directors of our Company to the eligible equity shareholders of the Company.
31. OBLIGATION OF COMPANY UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:
In accordance with the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and rules made there under, the Company has framed and adopted the policy for Prevention of Sexual Harassment at Workplace. Company was not in receipt of any complaint of sexual harassment during the year.
Number of complaints of sexual harassment received in the year:- NA
Number of complaints disposed off during the year:- NA
Number of cases pending for more than ninety days:- NA
32. CHANGES IN NATURE OF BUSINESS:
There was no change in nature of Business during the year.
33. CORPORATE SOCIAL RESPONSIBILITY:
Corporate Social Responsibility (CSR) is embedded in long term business strategy of company. The company is committed to local community and society at large. With the companies Act, 2013 mandating the corporate to contribute towards social development and welfare of society, the companys CSR initiatives help to elevate the quality of the life of the people. The provisions of Section 135 of the Companies Act, 2013 read with rule 9 of Companies (Corporate Social Responsibility Policy) Rules 2013 (including any statutory modification or amendment thereto or re-enactment thereof for the time being in force, are applicable to the company.
During the year under review the Committee met once during the year i.e on May 23, 2024. The details of the Meeting are as follows:
Sr. No. | Name of Director | Designation/ Nature of Directorship | Number of meetings of CSR Committee held during the year | Number of meetings of CSR Committee attended during the year |
1 | Niken Ravin Shah (DIN:07604022) | Independent Director, Chairman | 1 | 1 |
2 | Mahesh Pahalraj Makhija (DIN: 02700606) | Managing Director, Member | 1 | 1 |
3 | Prajwal J. Poojari (DIN: 07480513) | Independent Director, Member | 1 | 1 |
A. Composition of the CSR committee of the board:
There has been no change in the constitution of CSR Committee during the year. Following are the details of members of CSR Committee:
Name of the Directors | Nature of Directorship | Designation in Committee |
Niken Ravin Shah | Independent Director | Chairman |
Mahesh Pahalraj Makhija | Managing Director | Member |
Prajwal J. Poojari | Independent Director | Member |
B. Average net profit of the company for last three Financial Years for the purpose of computation of CSR is Rs 11,79,94,921.29/-.
C. CSR expenditure for Financial Year 2024-2025 is two per cent of the average net profits of the company made during the three immediately preceding financial years: Rs. 23,59,898.43/-.
D. Details of CSR spent during the Financial year:
Total amount to be spent in the Financial year - Rs. 23,59,898.43/-.
Excess Amount Spent last year - Rs. 12,700.17
Expendiiture done this year - Rs. 23,47,198.26 which was spent as under:
Rs. 13,00,000/- towards VARDHMAN BHARTI TRUST and Rs. 12,00,000 towards PRS PLAY RECREATION SPORTS FOUNDATION.
Amount unspent during the Financial Year - Nil
Manner in which the amount spent in the Financial year:
S. No. | CSR project or activity identified | Sector in which the project is covered | Projects or programs (1) Local area or other (2) Specify the State and district where projects or programs was undertaken | Amount outlay (budget) project or Programs wise (Amount in INR) | Amount spent: Direct or through Implementing agency (give details of implementing agency) (Amount in INR) |
1 | Donation | Education | Gujarat | 13,00,000/- | Vardhman Bharti Trust |
2 | Donation | Training to promote rural sports, nationally recognised sports, paralympic sports and olympic sports | Maharsahtra | 12,00,000/- | PRS PLAY RECREATION SPORTS FOUNDATION |
E. The Annual Report on CSR Activities is annexed herewith as Annexure II
34. DETAILS OF APPLICATIONS MADE OR ANY PROCEEDING PENDING UNDER THE INSOLVENCY AND BANKRUPTCY CODE 2016:
No application is made during the Financial Year 2024-25 by or against the Company and there are no proceedings pending under the Insolvency and Bankruptcy Code 2016.
35. A STATEMENT BY THE COMPANY WITH RESPECT TO THE COMPLIANCE OF THE PROVISIONS RELATING TO MATERNITY BENEFITS ACT, 1961:
The company has complied with provisions of Maternity Benefit Act,1961
36. LISTING FEES:
The listing fees payable for the Financial Year 2024-25 has been paid to National Stock Exchange of India Limited within due date.
37. HUMAN RESOURCES:
Your Company considers people as its biggest assets and Believing in People is at the heart of its human resource strategy. It has put concerted efforts in talent management and succession planning practices, strong performance management and learning and training initiatives to ensure that your Company consistently develops inspiring, strong and credible leadership.
Your Company has established an organization structure that is agile and focused on delivering business results. With regular communication and sustained efforts it is ensuring that employees are aligned on common objectives and have the right information on business evolution. Your Company strongly believes in fostering a culture of trust and mutual respect in all its employees seek to ensure that business world values and principles are understood by all and are the reference point in all people matters.
The current workforce breakdown structure has a good mix of employees at all levels. Your Board confirms that the remuneration is as per the remuneration policy of the Company.
As on March 31, 2025, the Company had only 144 employees.
38. DIRECTORS RESPONSIBILITY STATEMENT:
Pursuant to Section 134(5) of the Companies Act, 2013, the board of Directors, to the best of their knowledge and ability, confirm that:
i. In the preparation of the annual accounts, the applicable accounting standards have been followed and there are no material departures.
ii. They have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit/loss of the Company for that period.
iii. They have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.
iv. They have prepared the annual accounts on a going concern basis.
v. They have laid down internal financial controls to be followed by the Company and such internal financial controls are adequate and operating effectively.
vi. They have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
Based on the framework of internal financial controls and compliance systems established and maintained by the Company, work performed by the internal, statutory and secretarial auditors and external consultants and the reviews performed by management and the relevant board committees, including the audit committee, the board is of the opinion that the Companys internal financial controls were adequate and effective during the financial year 2024-25.
39. OTHER DISCLOSURES:
i. DISCLOSURE UNDER SECTION 43(a)(ii) OF THE COMPANIES ACT, 2013:
The Company has not issued any shares with differential rights as to dividend, voting or otherwise and hence no information as per provisions of Section 43(a)(ii) of the Act read with Rule 4(4) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.
ii. DISCLOSURE UNDER SECTION 54(1)(d) OF THE COMPANIES ACT, 2013:
The Company has not issued any sweat equity shares during the year under review and hence no information as per provisions of Section 54(1)(d) of the Act read with Rule 8(13) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.
iii. DISCLOSURE UNDER SECTION 62(1)(b) OF THE COMPANIES ACT.2013:
The Company has not issued any equity shares under Employees Stock Option Scheme during the year under review and hence no information as per provisions of Section 62(1)(b) of the Act read with Rule 12(9) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.
iv. DISCLOSURE UNDER SECTION 67(3) OF THE COMPANIES ACT, 2013:
During the year under review, there were no instances of non-exercising of voting rights in respect of shares purchased directly by employees under a scheme pursuant to Section 67(3) of the Act read with Rule 16(4) of Companies (Share Capital and Debentures) Rules, 2014 is furnished.
v. OTHER DISCLOSURES WITH RESPECT TO REGULATION 62 OF THE COMPANIES ACT, 2013:
During the year under review, the Company has approved Raising of funds,for an aggregate amount not exceeding Rs. 49,00,00,000 (Rupees Forty-Nine Crores Only) on August 29, 2024. The Company approved the Draft Letter of Offer dated 2nd December, 2025.
The Company received an In Principle approval on 13th January, 2025 and had withdrawn the Application for Rights Issue on 19th August, 2025.
40. REPORTING OF FRAUD:
The Auditors of the Company have not reported any instances of fraud committed against the Company by its officers or employees as specified under Section 143(12) of the Companies Act, 2013.
41. CAUTIONARY STATEMENTS:
Statements in this Annual Report, particularly those which relate to Management Discussion and Analysis as explained in the Corporate Governance Report, describing the Companys objectives, projections, estimates and expectations may constitute forward looking statements within the meaning of applicable laws and regulations. Actual results might differ materially from those either expressed or implied in the statement depending on the circumstances.
42. SHAREHOLDING OF DIRECTORS AS ON MARCH 31, 2025:
No other Director (except as mentioned below) holds any shares in the Company. The Company has not issued any convertible instruments
Sr. No. | Name of the Directors | Shareholding at the beginning of the year | Shareholding at the end of the year. |
1. | Mahesh Makhija Managing Director | 1,28,48,840 (71.98%) | 1,28,48,840 (71.98%) |
2. | Guddi Makhija Non-Executive Director (Resigned on August 23, 2025) | 1,50,500 (0.84%) | 1,50,500 (0.84%) |
43. BOARD-SKILLS/EXPERTISE/COMPETENCIES:
The Board of directors based on the recommendations of the Nomination and Remuneration Committee, identified the following core skills/expertise/competencies of Directors as required in the context of business of the Company for its effective functioning:
Sr. No | Skills/Expertise/Competencies |
1 | Leadership qualities |
2 | Industry knowledge and experience |
3 | Understanding of relevant laws, rules and regulations |
4 | Financial Expertise |
5 | Risk Management |
Following are the details of the skills and competence possessed by the Board of Directors:
Sr. No | Name of Directors | Leadership qualities | Industry knowledge and experience | Understanding of relevant laws, rules and regulations | Financial Expertise | Risk Management |
1 | Mahesh Makhija | Expert | Expert | Expert | Expert | Expert |
2 | Deena Nath Pathak | Expert | Expert | Expert | Expert | Expert |
3 | Prajwal Poojari | Expert | Expert | Expert | Expert | Expert |
4 | Niken Shah | Expert | Expert | Expert | Expert | Expert |
5 | Guddi Makhija (Resigned on August 23, 2025) | Expert | Expert | Expert | Expert | Expert |
6 | Sarita Mahajan | Expert | Expert | Expert | Expert | Expert |
The identified skills / competences are broad-based and marking of Proficient against a particular member does not necessarily mean the member does not possess the corresponding skills / competences.
44. DETAILS OF REMUNERATION TO ALL THE DIRECTORS AND KEY MANAGERIAL PERSONNEL:
Name of the Directors | Salary, Allowance, perquisites and other benefits | Performance- linked Income/Bonus/Commission Paid/Payable | Stock Option | Pension | Sitting Fees Paid |
Mr. Mahesh Makhija | 1,68,00,000 | - | - | - | - |
Mrs. Guddi Makhija (Resigned on August 23, 2025) | 5,00,000 | ||||
Mr. Niken Ravin Shah | - | - | - | - | 2,50,000 |
Mr. Prajwal Jayasheela Poojari | - | - | - | - | 2,50,000 |
Mr. Deena Nath Pathak | 15,28,100 | ||||
Mrs. Sarita Vijay Mahajan | 60,000 |
i. REMUNERATION TO KEY MANAGERIAL PERSONNEL OTHER THAN MD/MANAGER/WTD:
Sr. No | Particulars of Remuneration | Remuneration in (Rs.) till the date of employment | ||
Company Secretary (Toral Bhadra) | CFO (Sejal Mhatre) | Total | ||
1 | Gross salary (a) Salary as per provisions contained in section 17(1) of the Income-tax Act, 1961 | 6,00,000 | 13,66,100 | 19,66,100 |
(b) Value of perquisites u/s 17(2) Income- tax Act, 1961 | ||||
(c) Profits in lieu of salary undersection 17(3) Income-tax Act, 1961 | ||||
2 | Stock Option | - | - | |
3 | Sweat Equity | - |
||
4 | Commission | - | - | |
- as % of profit | ||||
- others, specify... | ||||
5 | Others, please specify | - | ||
Total | 6,00,000 | 13,66,100 | 19,66,100 |
ii. Disclosure of Managerial Remuneration:
Ratio of remuneration of each Director to the median remuneration of the employees of the Company for FY 202425 as well as the percentage increase in remuneration of each Director, Chief Financial Officer and Company Secretary is as under:
Name of Director/ Key Managerial Personnel | Ratio to median remuneration | % increase in remuneration over previous year |
Mrs. Guddi Makhija - (Non-Executive Directors) (Resigned on August 23, 2025) | 3.90:1 | 16.67% |
Mr. Mahesh Makhija - (Executive Directors) | 46.80:1 | 0.00% |
Mrs. Sejal Mhatre (CFO) | 3.81:1 | 9.05% |
Mrs. Toral Jailesh Bhadra (Company Secretary) | 1.67:1 | 53.06% |
A. Percentage increase in the median remuneration of employees in FY 2024-25: 30.70%
B. Number of permanent employees on the rolls of the Company as on March 31, 2025: 89
C. Comparison of average percentile increase in salary of employees other than the managerial personnel and the percentile increase in the managerial remuneration:
Particulars | % change in remuneration |
Average increase in salary of employees (other than managerial personnel) | 36.79% |
Average increase in remuneration of managerial personnel | 19.54% |
Affirmation: It is affirmed that the remuneration paid to the Directors, Key Managerial Personnel and other employees is as per the Remuneration Policy of the Company.
45. PENALTIES / PUNISHMENT/ COMPOUNDING OF OFFENCES:
Type | Section of the Companies Act | Brief Description | Details of Penalty / Punishment/ Compounding fees imposed | Authority [RD / NCLT/ COURT] | Appeal made, if any (give Details) |
A. COMPANY | |||||
Penalty | NONE | ||||
Punishment | |||||
Compounding | |||||
B. DIRECTORS | |||||
Penalty | NONE | ||||
Punishment | |||||
Compounding | |||||
C. OTHER OFFICER | S IN DEFAULT | ||||
Penalty | NONE | ||||
Punishment | |||||
Compounding |
46. GENERAL:
a) 8th Annual General Meeting
Date | Time | Venue |
29th September, 2025 | 11:00 AM | through Video Conferencing or Other Audio Visual means |
b) Financial Calendar for the year 2024-2025
Financial year | 1st April, 2024 to 31st March, 2025 (both days inclusive) |
Book Closure Dates | 23-09-2025 to 29-09-2025 |
c) Listing of Equity Shares on Stock Exchange and Stock Codes
Listing on Stock Exchange:
NSE Limited ("NSE")
Exchange Plaza, C-1, Block-G,
Bandra-Kurla Complex, Bandra (E),
Mumbai-400051
d) Location and time, where Annual General Meeting (AGM) for the last 3 years were held is given below:
Financial Year | AGM | Date | Time | Location |
2023-24 | 7th | Friday , September 27, 2024 | 02.00 p.m. | Through Video Conferencing or Other Audio Visual means |
2022-23 | 6th | Monday, September 25, 2023 | 11.00 a.m. | Through Video Conferencing or Other Audio |
Visual means | ||||
2021-22 | 5th | Wednesday, September 14, 2022 | 11.00 a.m. | A1 A2/B1 B2, Navkala Bharti Bldg Plot No 16, Prabhat Colony, Opp Near Santacruz Bus Depot, Santacruz East, Mumbai 400055. |
e) Stock Market Date and their Performance v/s S&P NSE Sensex
The high/low of the market price of the shares of the Company is as follows:
Month |
NSE (Rs.) |
|
High | Low | |
April-2024 |
122 | 102.55 |
May-2024 |
117.3 | 96.1 |
June-2024 |
144.9 | 90.25 |
July-2024 |
153.9 | 112.75 |
August-2024 |
142.3 | 107.75 |
September-2024 |
141.7 | 120.3 |
October-2024 |
123 | 103.15 |
November-2024 |
118 | 102 |
December-2024 |
123.5 | 100.6 |
January-2025 |
120 | 101.4 |
February-2025 |
113.4 | 93.2 |
March-2025 |
110 | 72.35 |
f) Registrar And Share Transfer Agent (RTA): Bigshare Services Private Limited
Office No. S6-2, 6th Floor Pinnacle Business Park, Next to Ahura Centre Mahakali Caves Road, Andheri (East).
Tel: 022-6263 8200.
Website: https://www.bigshareonline.com/
Share transfer system:
The Board has the authority for approving transfer, transmission of the Companys securities. The Company ensures that the Annual Compliance Certificate pursuant to regulations 40(9) and 40 (10) of the SEBI Listing Regulations are filed with the Stock Exchanges.
As per SEBI Notification No. SEBI/LAD-NRO/GN/2018/24 dated June 8, 2018 and further amendment vide Notification No. SEBI/LAD-NRO/GN/2018/49 dated November 30, 2018, requests for effecting transfer of securities (except in case of transmission or transposition of securities) cannot be processed from April 1, 2019 unless the securities are held in the dematerialized form with the depositories.
The Board appreciates that all the members are holding shares in dematerialized form.
Distribution of shareholding:
Nominal Value of Shares: Rs. 10
Category (Shares) |
Shareholders |
Shares |
||
Number | % | Number | % | |
1-5000 |
4 | 02582 | 1600 | 00009 |
5001- 10000 |
972 | 627502 | 9720000 | 54454 |
10001-20000 |
236 | 152356 | 4720000 | 26443 |
20001-30000 |
92 | 59393 | 2760000 | 15462 |
30001-40000 |
52 | 33570 | 2080000 | 11653 |
40001-50000 |
44 | 28405 | 2200000 | 12325 |
50001-100000 |
68 | 43899 | 5310000 | 29748 |
100001 and above |
81 | 52292 | 151708400 | 849907 |
Total |
1549 | 100.00 | 1,78,50,000 | 1000000 |
g) Dematerialization of Shares:
The Companys shares are required to be compulsorily traded on Stock Exchanges in dematerialized form. The number of shares as on 31st March, 2025 held in dematerialized and physical form are as under:
Particulars | No. of Shares | % |
NSDL | 14591960 | 81.75 |
CDSL | 3258040 | 18.25 |
Physical | 0 | 0 |
Total | 17850000 | 100.00 |
h) Compliance with mandatory and non-mandatory requirements of the Listing Regulations:
The Company has complied with all mandatory requirements of Listing Regulations and has not adopted any nonmandatory requirements which are not applicable to the Company.
47. CORPORATE GOVERNANCE:
The Company does not fall under purview of Regulations of Corporate Governance.
Pursuant to Regulation 15 of SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015, the provisions of reporting of Corporate Governance as specified in Regulation 27 (2) is not applicable to the Company, as it is SME Listed Company.
Though the Corporate Governance is not applicable to the Company, the Company has given certain disclosures as a practice of good corporate governance.
48. ACKNOWLEDGEMENTS:
Your Directors would like to express deep sense of appreciation for the assistance and co-operation received from the Financial Institutions, Banks, Government Authorities and Shareholders and for the devoted service by the Executives, staff and workers of the Company. The Directors express their gratitude towards each one of them.
By Order of the Board of Directors |
For QMS MEDICAL ALLIED SERVICES LIMITED |
SD/- |
Mahesh Makhija |
DIN:02700606 |
Managing Director |
Date: August 29, 2025 |
Place: Mumbai |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.